Navigation path

Pharmaceuticals - Union Register


Register of orphan medicinal products


Product information

Apomorphine hydrochloride (inhalation use)

EU orphan designation number: EU/3/06/349   
Active ingredient: Apomorphine hydrochloride (inhalation use)
Indication: Treatment of off-periods in Parkinson’s disease not responding to oral treatment
Sponsor: Vectura Group plc
1 Prospect West, Chippenham, Wiltshire SN14 6FH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
20/02/2006 Orphan designation EMEA/OD/086/05 (2006)546 of 16/02/2006